Report for National Audit of Schizophrenia 2

Findings from the second round of the National Audit of Schizophrenia (NAS2)

Schizophrenia is a severe mental illness that affects almost 300,000 people in the UK. Some people who develop the condition make a complete recovery and never experience another episode, but most people experience a recurrence at some point and for many it is a long term condition that they must learn to live with.

Acknowledging the need to improve the care for these patients, the following organisations entered into partnership for the National Audit of Schizophrenia (NAS): British Association for Psychopharmacology; College of Mental Health Pharmacy; Healthcare Quality Improvement Partnership (HQIP); Mind; Prescribing Observatory for Mental Health (POMH-UK); Rethink Mental Illness; Royal College of General Practitioners (RCGP);Royal College of Nursing (RCN)and Royal Pharmaceutical Society of Great Britain.

Two years ago the first round of the National Audit of Schizophrenia NAS1( Royal College of Psychiatrists,2012) on 5091 patients found very significant deficiencies in the monitoring and management of physical health problems in people with schizophrenia, deficiencies in some aspects of medication prescribing practice and how clinicians communicate with service users and carers.

The NAS2 audit set out to collect case record data on 100 service users, living in the community, from each of the Mental Health Trusts/Health Boards in England and Wales and obtained a final database of 5,608 records (an 88% response rate). Data were also collected from service users and carers.

Copies of the full NAS2 National Report, our local summary and the ‘Second National Audit of Schizophrenia – what you need to know guide’, are available to download.